{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/114124742"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "For venlafaxine this was also the case, a significant increase in off-label prescription, but mostly for anxiety disorders.Especially the increase in off-label prescription for hyperactivity and worries about behavior are worrying because the efficacy of SSRIs for ADHD is not established." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "blogspot.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/79870986"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/114124742"] } } }
